Speaker(s): 

Jonathan Hughes, PharmD, BCACP, Staff Member, Ascension Saint Thomas Medical Partners - has nothing to disclose.

Moderator(s): 

Daniel Longyhore, PharmD, EdD, BCACP, Staff Member, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Describe recent state-level legislative trends that authorize or reimburse pharmacist provided clinical services. 
• Compare the operational implications of differing state statutes, including prescriptive authority, supervision requirements, and payer mandates.
• Evaluate how these policy shifts can be leveraged to advance sustainable clinical pharmacy services within health systems.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Daniel Longyhore, PharmD, EdD, BCACP; Eric Wright, PharmD, MPH; Melissa Kern, MPH and Lisabeth Karetsky, CPhT have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose: Tammy McCormick, RDN, Tristan Maiers, PharmD

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None